US 9382547
Human optimized Bacillus anthracis protective antigen
granted A61KA61K2039/53A61K2039/55511
Quick answer
US patent 9382547 (Human optimized Bacillus anthracis protective antigen) held by United States of America as represented by the Secretary of the Air Force expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/53, A61K2039/55511, A61K39/07, A61P